Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
the results of this study may provide an easy non pharmacological modality for dealing with diabetic polyneuropathic pain. Also, the outcome of this study will guide physiotherapists to develop a new noninvasive treatment modality that may improve patient symptoms and promotes their social participation , this in turn may add to clinical role played by therapists in management of diabetic polyneuropathy. In Addition, increased knowledge of the influence of High tone power therapy on neuropathic pain
This study will be carried out on sixty diabetic male patients with polyneuropathy with ages 50-60 years . Patient will be randomly assigned to two grouos. group A will include 30 type 2 diabetic patients with diabetic polyneuropathy. Theses patients will receive High tone power therapy with Frequencies continuously will be scanned from 4096 Hz to 31768 Hz, allowing for a much higher power of up to 5000 mW to be introduced for 3 times per week, for 3 months for 30 minutes every session.
Group B :
This group will include 30 type 2 diabetic patients with diabetic neuropathy. These patients will receive TENS with applied frequencies range from 2 to 120 Hz. for 3 times per week for 30 minutes every session during 3 months of intervention.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High tone power therapy | Experimental | 30 type 2 diabetic patients with diabetic polyneuropathy. Theses patients will receive High tone power therapy |
|
| TENS | Active Comparator | 30 type 2 diabetic patients with diabetic neuropathy. These patients will receive TENS |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| high tone power therapy | Device | patients will be assigned into 2 groups with pre and post treatment protocol application. all patients will be thoroughly evaluated before and after treatment protocol application. |
| Measure | Description | Time Frame |
|---|---|---|
| Neuropathic pain by DN4 (Douleur Neuropathique en 4 Questions) Questions) | t is a questionnaire has been developed to facilitate detection of neuropathic pain.total score is 10 .diagnosis of neuropathic pain is 4/10. | up to 12 weeks |
| Pain pressure threshold algometer | devices that can be used to identify the pressure and/or force eliciting a pressure-pain threshold. It has been noted in pressure | up to 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Glyclated Haemoglobin Level (HbA1c) | Increasing HbA1c level is significantly associated with increased prevalence of DPN as well as PDPN and non-painful DPN | up to 12 weeks |
| life disability | the World Health Organization Quality of Life Brief Version (WHOQOL-BREF) is an abbreviated, 26-item version of the 100-item WHOQOL-100 quality of life measure. The WHOQOL-BREF addresses four quality of life domains: physical health, psychological health, social relationships and environment. Then calculate a domain score for each of the health domains by calculating the average answer points for each domain (sum of answer points divided by number of questions) and multiplying the result by the number 4. |
Not provided
Inclusion Criteria:
The patient selection will be according to the following criteria:
Exclusion Criteria:
The participants will be excluded if they meet one of the following criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| zeinab Awadallah, master | Contact | +201285819342 | zeezee.awad88@hotmail.com | |
| Alaa El-Moatasem, lecturer | Contact | 01006625054 | alaamotasem@rocketmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Om Elmasryeen Genral Hospital | Recruiting | Giza | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D004561 | Transcutaneous Electric Nerve Stimulation |
| ID | Term |
|---|---|
| D004599 | Electric Stimulation Therapy |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
| D012046 | Rehabilitation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| TENS | Device | These patients will receive TENS with applied frequencies range from 2 to 120 Hz. for 3 times per week for 30 minutes every session during 3 months of intervention in addition to medications. |
|
| up to 12 weeks |
| D000698 |
| Analgesia |
| D000760 | Anesthesia and Analgesia |